Innovation Focused

Aura Biosciences is an innovation-driven company focused on the development of drugs using tumor targeted Viral Nanoparticles, breakthrough technology discovered and patented by Dr. John Schiller at the National Cancer Institute (NCI).

This is a novel approach that harnesses the power of synthetic biology and viral evolution. Aura has developed methods to manufacture these empty viral structures and combine them with multiple types of drugs to create a new generation of highly efficient targeted molecules.